Β-CATENIN

Clinical trials for Β-CATENIN explained in plain language.

Never miss a new study

Get alerted when new Β-CATENIN trials appear

Sign up with your email to follow new studies for Β-CATENIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New cancer drug targets genetic weakness in advanced tumors

Disease control Recruiting now

This early-stage trial is testing a new drug called FOG-001 for people with advanced or spreading cancers that have specific genetic mutations. Researchers want to find the safest dose and see if the drug can shrink tumors or slow cancer growth. The study will include 575 partici…

Matched conditions: Β-CATENIN

Phase: PHASE1, PHASE2 • Sponsor: Parabilis Medicines, Inc. • Aim: Disease control

Last updated Mar 27, 2026 12:39 UTC

Β-CATENIN

Get alerted when new Β-CATENIN trials appear

New cancer drug targets genetic weakness in advanced tumors